Data Sheet 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.pdf

Data Sheet 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.pdf

Introduction<p>Genetic polymorphisms in CYP2D6 and CYP2C19 significantly influence the metabolism, efficacy, and safety of antidepressant medications. Limited data exist on the prevalence of these actionable pharmacogenetic variants in the Central Indian population. This study aimed to determi...

保存先:

書誌詳細
第一著者:	Santenna Chenchula (14775163) (author)
その他の著者:	Atal Shubham (22679330) (author), Rozatkar Abhijit (22679333) (author), Tamonud Modak (22679336) (author), Kohat Komal (22679339) (author), Ratinder Jhaj (22679342) (author), Singh Jitendra (22679345) (author), Satyaprakash V. (22679348) (author), Sadasivam Balakrishnan (22679351) (author)
出版事項:	2025
主題:	Pharmacology pharmacogenetics CYP2D6 CYP2C19 antidepressants common mental disorders indian population copy number variation CPIC
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif
著者:: Santenna Chenchula (14775163)
出版事項: (2025)

Image 1_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif
著者:: Santenna Chenchula (14775163)
出版事項: (2025)

Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review
著者:: Emytis Tavakoli (14127837)
出版事項: (2025)

Image 1_Evaluation of the relationship between cytochrome P450 (CYP) 1A2 gene copy number variation and CYP1A2 protein content and enzyme activity in canine liver.jpeg
著者:: Francisco Gonzales Zamora (21761210)
出版事項: (2025)

Table 1_Evaluation of the relationship between cytochrome P450 (CYP) 1A2 gene copy number variation and CYP1A2 protein content and enzyme activity in canine liver.docx
著者:: Francisco Gonzales Zamora (21761210)
出版事項: (2025)

Data Sheet 1_StarTRAC-CYP2D6: a method for CYP2D6 allele-specific copy number determination using digital PCR.pdf
著者:: Wendy Y. Wang (5030501)
出版事項: (2025)

Sequence analysis of gorilla CYP4B1.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Functional analysis of primate CYP4B1 orthologs.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Oligonucleotides designed for sequencing CYP4B1 orthologs from apes, introducing amino acid changes, and establishing CYP4B1-EGFP fusion proteins.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Expression analysis of recombinant purified CYP4B1 enzymes.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Artificial engineering of a full-length gorilla CYP4B1.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Table 1_Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review.docx
著者:: Luiz Carlos da Costa-Junior (21727631)
出版事項: (2025)

Functional analysis of mutated CYP4B1 enzymes in HepG2 cells.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Systematic analysis of the activity of different CYP4B1 orthologs during primate evolution.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Functional consequences of the four critical amino acid substitutions in Homo sapiens and rabbit CYP4B1.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Activity, expression and localization of CYP4B1-EGFP fusion proteins in HuH-7 cells.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Clinical trials in depression: Integrated collection across EU and US registries
著者:: Kate Stewart (21786413)
出版事項: (2025)

Image 1_Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder.tiff
著者:: Daniel Hain (234962)
出版事項: (2025)

Active Site Residues Contribute to the Multistep Dynamics of Dicyclotyrosine Bound to CYP121A1 of Mycobacterium tuberculosis
著者:: Patil Pranita Uttamrao (22474784)
出版事項: (2025)

Association between different CYP2R1, CYP27B1, CYP24A1, and DBP SNPs genotypes and the clinical characteristics of multiple sclerosis.
著者:: Laith AL-Eitan (6841382)
出版事項: (2025)

<i>In silico</i> modeling of potential key amino acid positions for the functional activity of mammalian CYP4B1.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

PTable S4 Expression validation of CYP1B1.
著者:: Li-Hong Chen (610826)
出版事項: (2025)

CYP2R1, CYP27B1, CYP24A1, and <i>DBP</i> (GC) SNPs, their minor allele frequencies, and HWE p-value in cases and controls.
著者:: Laith AL-Eitan (6841382)
出版事項: (2025)

Validation of CYP1B1 expression in THP-1 monocytes.
著者:: Li-Hong Chen (610826)
出版事項: (2025)

Analysis on ArcDFI’s Compound-CYP Interaction Block for drug-food compound pair Midazolam and Berberine.
著者:: Mogan Gim (22439477)
出版事項: (2025)

Analysis on ArcDFI’s Compound-CYP Interaction Block for drug-food compound pair Sulfonylurea and Salicylate.
著者:: Mogan Gim (22439477)
出版事項: (2025)

CYP gene expression of indoxyl sulfate (IS) in primary human hepatocytes.
著者:: Masao Togao (21696599)
出版事項: (2025)

Genetic models and distributions of SNPs within (<i>CYP2R1, CYP27B1, CYP24A1,</i> and <i>DBP</i>) genes in 192 cases and 196 controls.
著者:: Laith AL-Eitan (6841382)
出版事項: (2025)

Restoring the activity of gibbon and two great ape CYP4B1 orthologs by p.C106R and p.H244R substitution.
著者:: Saskia Hüsken (21616072)
出版事項: (2025)

Knockdown of CYP1B1 inhibited monocytes activation and tryptophan metabolism.
著者:: Li-Hong Chen (610826)
出版事項: (2025)

The transfection efficiency of CYP1B1 knockdown in THP-1 cells.
著者:: Li-Hong Chen (610826)
出版事項: (2025)

Identification of tryptophan metabolism-related gene CYP1B1 in sepsis.
著者:: Li-Hong Chen (610826)
出版事項: (2025)

CYP3A activity in primary human hepatocytes treated with indoxyl sulfate (IS).
著者:: Masao Togao (21696599)
出版事項: (2025)

CYP3A activity in DPX-2 cells treated with each test compound.
著者:: Masao Togao (21696599)
出版事項: (2025)

Image 1_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
著者:: Qianqian Du (5773832)
出版事項: (2025)

Image 3_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
著者:: Qianqian Du (5773832)
出版事項: (2025)

Image 2_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
著者:: Qianqian Du (5773832)
出版事項: (2025)

Image 4_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
著者:: Qianqian Du (5773832)
出版事項: (2025)

Image 5_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
著者:: Qianqian Du (5773832)
出版事項: (2025)

Image 8_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.png
著者:: Qianqian Du (5773832)
出版事項: (2025)